Alphabetical Search: 1 2 3 4 5 6 7 8 9 A B C D E F G H I K M N P T U X
  Searchbox: Selection of cyclic nucleotides by properties.
Subcategories for Cyclic Nucleotides
PDE- resistant PKA Inhibitors
PDE- resistant PKA Activators
Epac Agonists
Epac- negative Controls
Other PKA Activators
PDE- resistant PKG Inhibitors
PDE- resistant PKG Activators
Other Activators of PKG
Affinity Gels
cAMP Ligands for Immobilization
cGMP Ligands for Immobilization
Caged Cyclic Nucleotides
Special Task Cyclic Nucleotides
Modulators of CNG Ion Channels
Fluorescent Cyclic Nucleotides
Peptide-based PKG Inhibitors
Metabolically activatable cNMP
cNMP with Pyrimidine Nucleobase
Classification
Bulk
cAMP modified at the exocyclic oxygen - equatorial (Rp-)
cAMP modified at the exocyclic oxygen - axial (Sp-)
cGMP modified at the exocyclic oxygen - equatorial (Rp-)
cGMP modified at the exocyclic oxygen - axial (Sp-)
Position of Purine Nucleobase Modification:
Description:
Lipophilicity

Lipophilicity ranking is based on log kw data. To be membrane-permeant, analogues should have a log kw of at least 1.2

<< Back
Forgot your password?
Register
Username:
Password:
What is new!

June 07, 2010

New NAD and cADPR analogues !

Latest additions to our expanding product line of NAD+ and cADPR analogues are:

8-Br-7-CH-cADP... [more...]

May 21, 2010

New Epac references !

Two new collaborative papers describing the use of the membrane-permeant Epac activator... [more...]